Broad, MilliporeSigma issue call to make access to CRISPR freerGene-editing with CRISPR/Cas9 is promising a revolution in medicine, but battles over intellectual property (IP) have made it Share XBroad, MilliporeSigma issue call to make access to CRISPR freerhttps://pharmaphorum.com/news/broad-milliporesigma-issue-call-to-make-access-to-crispr-freer/
